Connect with us

Why Energy Penny Stocks Are Up Today and 3 Small-Caps to Watch

Energy penny stocks are flying right now; which ones are on your June watchli
The post Why Energy Penny Stocks Are Up Today and 3 Small-Caps to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Published

on

3 Energy Penny Stocks to Watch in June 2021

Finding penny stocks in 2021 is all about understanding where movement may come from. With penny stocks, it’s all about speculation. And, given that we are in one of the most speculative periods of the past decade, volatility is higher than ever. 

Factor in the effects of social media like Reddit penny stocks and more, and we get a market that fluctuates greatly. Because of this, the best course of action is to thoroughly research every company on your list of penny stocks to watch. This is the best way to know exactly what you’re getting into.

Now, with energy penny stocks, there are a few things specific to look out for. In June, energy companies are on the rise as the U.S. sees lower case numbers for Covid than in many months prior. This means that more people are comfortable with traveling, and thus, consuming more energy. Because of this, there is a great deal of bullish sentiment in the energy industry right now. 

[Read More] 5 Robinhood Penny Stocks That You Should Know About in May

But, we also have to factor in common things to look out for outside of energy-related aspects. For this reason, investors need to understand current market trends. As stated before, this includes social media, the pandemic, long-term fears of inflation, and blockchain/cryptocurrency. Because there are so many things at play, the opportunities to see profits, as a result, can be large. However, this means that the chances of seeing losses can also be high. 

The best way to avoid this is by having a solid understanding of the companies you’re interested in, as well as how to predict certain trends and patterns. This will help you to stay ahead when it comes time to make decisions about entering or exiting a position. Considering all of this, let’s take a look at three hot penny stocks that have investors excited right now. 

3 Penny Stocks to Watch in 2021 

  1. ENGlobal Corp. (NASDAQ: ENG)
  2. Tellurian Inc. (NASDAQ: TELL
  3. Orbital Energy Group Inc. (NASDAQ: OEG)

ENGlobal Corp. (NASDAQ: ENG)

ENGlobal Corp. is a provider of project solutions for both traditional and renewable energy companies in the U.S. and abroad. It operates through two segments which include commercial and government. With these, it can provide advanced solutions for a variety of energy needs. 

On Tuesday, June 1st, shares of ENG stock were up by as much as 36% during midday trading. This is a staggering gain and is indicative of the overall bullish sentiment in the energy industry today.

While no news came out of ENG stock today, we can look at its Q1 2021 results announced at the beginning of May. In the quarter, ENG brought in revenue of around $12.45 million, with a net income of $46,000. This is compared to a net income of $1.1 million in the same quarter of the previous year. 

CEO of the company, Mark A. Hess, attributed this to the fact that “our company, like most others in the energy industry, has been materially affected by the reaction to the Covid-19 epidemic. We were fortunate that we were able to work through the backlog in place last year when the pandemic started.” 

Hess goes on to state that this year should see some major improvement as vaccines are distributed and case numbers decline. And, given that it also works in renewable energy, such as green fuels and solar, the growth potential for ENGlobal Corp. could be in the long term. Considering all of this, will it be on your list of penny stocks to watch?

Tellurian Inc. (NASDAQ: TELL)

Tellurian Inc. is a penny stock we’ve covered numerous times in the past few months. And, while its gain today of 3.4% or so is not as much as ENG or OEG stock, it is still worth noticing. And, last week, Tellurian Inc. made headlines after announcing some big news. Before we get into it, let’s talk about what TELL does.

Tellurian is a provider of natural gas and liquefied natural gas products. It owns several facilities around the country, including an LNG terminal property in southwest Louisiana as well as 72 producing wells and over 9,300 acres in north Louisiana. 

[Read More] 4 Cheap Penny Stocks To Buy For Under $1 On Robinhood & Webull

Very recently, big news dropped when Tellurian signed into a long-term agreement to supply liquid natural gas or LNG from its Driftwood production facility to Gunvor Singapore. Over 10 years, this agreement will supply 3 million tonnes per annum, covering more than 10% of its total capacity. This should bring in around $12 million in revenue, at current market prices. 

The Driftwood development is one with a major capacity, but to make it profitable, large orders like these need to continue coming through. While this is only one part of the plan moving forward, this deal should help to put TELL on the right track for the development of this property. Considering this, TELL stock could be worth keeping an eye on. 

Penny_Stocks_to_Watch_Tellurian Inc. (TELL Stock Chart)

Orbital Energy Group Inc. (NASDAQ: OEG) 

One of the largest gainers of the day is OEG stock, bringing in roughly 58% gains by midday. Shares of OEG pushed up by over $2, making it technically, no longer a penny stock at over $5.50 per share. Over the last year or so, OEG stock has skyrocketed in the triple-digit percentage points. This is due to a variety of reasons. 

For one, OEG is one of the most diversified energy companies in the industry. It operates several subsidiaries, including Orbital Power Services, Orbital Solar Services, Orbital Telecom Services, and Orbital Gas Systems. These all allow it to cover many unique, and potentially profitable markets in the U.S. Today, OEG announced that its subsidiary, Gibson Technical Services, was awarded a nearly 700-mile long engineering and construction project in Central Mississippi. 

“The award of this project from such a well-respected telecommunication service provider as TEC confirms GTS’s ability to deliver the highest quality engineering and construction services. I am proud of the entire GTS group for the teamwork.”

CEO of GTS, Mike McCracken

So considering its big gains today and the large momentum around this deal, OEG stock should be on your penny stocks watchlist for 2021.  

Penny_Stocks_to_Watch_Orbital Energy Group Inc. (OEG Stock Chart)

Energy Penny Stocks Continue to See Momentum 

With energy penny stocks, it’s important to consider a few things. For one, what is the overall industry doing? With another industry, it may be better to stick to company-specific events. However, with energy, big factors can often have a large effect on most companies within it.

[Read More] 4 Hot Penny Stocks For Your Reopening Watch List In June 2021

Consider that Covid cases are also decreasing at a major rate, and we see that the energy demand could continue to rise shortly. With all of this in mind, hopefully, we can continue to see major momentum with energy penny stocks in the coming months. 

The post Why Energy Penny Stocks Are Up Today and 3 Small-Caps to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Uncategorized

Pharma industry reputation remains steady at a ‘new normal’ after Covid, Harris Poll finds

The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45%…

Published

on

The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45% of US respondents in 2023, according to the latest Harris Poll data. That’s exactly the same as the previous year.

Pharma’s highest point was in February 2021 — as Covid vaccines began to roll out — with a 62% positive US perception, and helping the industry land at an average 55% positive sentiment at the end of the year in Harris’ 2021 annual assessment of industries. The pharma industry’s reputation hit its most recent low at 32% in 2019, but it had hovered around 30% for more than a decade prior.

Rob Jekielek

“Pharma has sustained a lot of the gains, now basically one and half times higher than pre-Covid,” said Harris Poll managing director Rob Jekielek. “There is a question mark around how sustained it will be, but right now it feels like a new normal.”

The Harris survey spans 11 global markets and covers 13 industries. Pharma perception is even better abroad, with an average 58% of respondents notching favorable sentiments in 2023, just a slight slip from 60% in each of the two previous years.

Pharma’s solid global reputation puts it in the middle of the pack among international industries, ranking higher than government at 37% positive, insurance at 48%, financial services at 51% and health insurance at 52%. Pharma ranks just behind automotive (62%), manufacturing (63%) and consumer products (63%), although it lags behind leading industries like tech at 75% positive in the first spot, followed by grocery at 67%.

The bright spotlight on the pharma industry during Covid vaccine and drug development boosted its reputation, but Jekielek said there’s maybe an argument to be made that pharma is continuing to develop innovative drugs outside that spotlight.

“When you look at pharma reputation during Covid, you have clear sense of a very dynamic industry working very quickly and getting therapies and products to market. If you’re looking at things happening now, you could argue that pharma still probably doesn’t get enough credit for its advances, for example, in oncology treatments,” he said.

Read More

Continue Reading

Spread & Containment

I created a ‘cosy game’ – and learned how they can change players’ lives

Cosy, personal games, as I discovered, can change the lives of the people who make them and those who play them.

Published

on

By

Cosy games exploded in popularity during the pandemic. Takoyaki Tech/Shutterstock

The COVID pandemic transformed our lives in ways many of us are still experiencing, four years later. One of these changes was the significant uptake in gaming as a hobby, chief among them being “cosy games” like Animal Crossing: New Horizons (2020).

Players sought comfort in these wholesome virtual worlds, many of which allowed them to socialise from the safety of their homes. Cosy games, with their comforting atmospheres, absence of winning or losing, simple gameplay, and often heartwarming storylines provided a perfect entry point for a new hobby. They also offered predictability and certainty at a time when there wasn’t much to go around.

Cosy games are often made by small, independent developers. “Indie games” have long been evangelised as the purest form of game development – something anyone can do, given enough perseverance. This means they can provide an entry point for creators who hadn’t made games before, but were nevertheless interested in it, enabling a new array of diverse voices and stories to be heard.

In May 2020, near the start of the pandemic, the small poetry game A Solitary Spacecraft, which was about its developer’s experience of their first few months in lockdown, was lauded as particularly poignant. Such games showcase a potential angle for effective cosy game development: a personal one.

Personal themes are often explored through cosy games. For instance, Chicory and Venba (both released in 2023) tackle difficult topics like depression and immigration, despite their gorgeous aesthetics. This showcases the diversity of experiences on display within the medium.

However, as the world emerges from the pandemic’s shadow, the games industry is facing significant challenges. Economic downturns and acquisitions have caused large layoffs across the sector.

Historically, restructurings like these, or discontent with working conditions, have led talented laid-off developers to create their own companies and explore indie development. In the wake of the pandemic and the cosy game boom, these developers may have more personal stories to tell.

Making my own cosy game

I developed my own cosy and personal game during the pandemic and quickly discovered that creating these games in a post-lockdown landscape is no mean feat.

What We Take With Us (2023) merges reality and gameplay across various digital formats: a website, a Discord server that housed an online alternate reality game and a physical escape room. I created the game during the pandemic as a way to reflect on my journey through it, told through the videos of game character Ana Kirlitz.

The trailer for my game, What We Take With Us.

Players would follow in Ana’s footsteps by completing a series of ten tasks in their real-world space, all centred on improving wellbeing – something I and many others desperately needed during the pandemic.

But creating What We Take With Us was far from straightforward. There were pandemic hurdles like creating a physical space for an escape room amid social distancing guidelines. And, of course, the emotional difficulties of wrestling with my pandemic journey through the game’s narrative.

The release fared poorly, and the game only garnered a small player base – a problem emblematic of the modern games industry.

These struggles were starkly contrasted by the feedback I received from players who played the game, however.

This is a crucial lesson for indie developers: the creator’s journey and the player’s experience are often worlds apart. Cosy, personal games, as I discovered, can change the lives of those who play them, no matter how few they reach. They can fundamentally change the way we think about games, allow us to reconnect with old friends, or even inspire us to change careers – all real player stories.

Lessons in cosy game development

I learned so much about how cosy game development can be made more sustainable for creators navigating the precarious post-lockdown landscape. This is my advice for other creators.

First, collaboration is key. Even though many cosy or personal games (like Stardew Valley) are made by solo creators, having a team can help share the often emotional load. Making games can be taxing, so practising self-care and establishing team-wide support protocols is crucial. Share your successes and failures with other developers and players. Fostering a supportive community is key to success in the indie game landscape.

Second, remember that your game, however personal, is a product – not a reflection of you or your team. Making this distinction will help you manage expectations and cope with feedback.

Third, while deeply considering your audience may seem antithetical to personal projects, your game will ultimately be played by others. Understanding them will help you make better games.

The pandemic reignited the interest in cosy games, but subsequent industry-wide troubles may change games, and the way we make them, forever. Understanding how we make game creation more sustainable in a post-lockdown, post-layoff world is critical for developers and players alike.

For developers, it’s a reminder that their stories, no matter how harrowing, can still meaningfully connect with people. For players, it’s an invitation to embrace the potential for games to tell such stories, fostering empathy and understanding in a world that greatly needs it.


Looking for something good? Cut through the noise with a carefully curated selection of the latest releases, live events and exhibitions, straight to your inbox every fortnight, on Fridays. Sign up here.


Adam Jerrett does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

Government

The SNF Institute for Global Infectious Disease Research announces new advisory board

From identifying the influenza virus that caused the pandemic of 1918 to developing vaccines against pneumococcal pneumonia and bacterial meningitis in…

Published

on

From identifying the influenza virus that caused the pandemic of 1918 to developing vaccines against pneumococcal pneumonia and bacterial meningitis in the 1970s, combating infectious disease has a rich history at Rockefeller. That tradition continues as the Stavros Niarchos Foundation Institute for Global Infectious Disease Research at Rockefeller University (SNFiRU) caps a successful first year with the establishment of a new advisory board.

Credit: Lori Chertoff/The Rockefeller University

From identifying the influenza virus that caused the pandemic of 1918 to developing vaccines against pneumococcal pneumonia and bacterial meningitis in the 1970s, combating infectious disease has a rich history at Rockefeller. That tradition continues as the Stavros Niarchos Foundation Institute for Global Infectious Disease Research at Rockefeller University (SNFiRU) caps a successful first year with the establishment of a new advisory board.

This international advisory board was created in part to give guidance on how to best use SNFiRU’s resources, as well as bring forward innovative ideas concerning new avenues of research, public education, community engagement, and partnership projects.

SNFiRU was established to strengthen readiness for and response to future health crises, building on the scientific advances and international collaborations forged in the context of the COVID-19 pandemic. Launched with a $75 million grant from the Stavros Niarchos Foundation (SNF) as part of its Global Health Initiative (GHI), the institute provides a framework for international scientific collaboration to foster research innovations and turn them into practical health benefits.

SNFiRU’s mission is to better understand the agents that cause infectious disease and to lower barriers to treatment and prevention globally. To speed this work, the institute launched numerous initiatives in its inaugural year. For instance, SNFiRU awarded 31 research projects in 29 different Rockefeller laboratories for over $5 million to help get collaborative new research efforts off the ground. SNFiRU also supports the Rockefeller University Hospital, where clinical studies are conducted, and brought on board its first physician-scientist through Rockefeller’s Clinical Scholars program. “One of the surprises was the scope of interest from Rockefeller scientists in using their talents to tackle important infectious disease problems,” says Charles M. Rice, Maurice R. and Corinne P. Greenberg Professor in Virology at Rockefeller and director of SNFiRU. “The research topics range from the biology of infectious agents to the dynamics of the immune response to pathogens, and also include a number of infectious disease-adjacent studies.”

In the past 12 months, SNFiRU often brought together scientists studying different aspects of infectious disease as a way to spur new collaborations. In addition to hosting its first annual day-long symposium, SNFiRU initiated a Young Scientist Forum for students and post-doctoral fellows to meet regularly, facilitating cross-laboratory thinking. A bimonthly seminar series has also been established on campus.

Another aim of SNFiRU is to develop relationships with community-based organizations, as well as design and participate in community-engaged research, with a focus on low-income and minority communities. To that end, SNFiRU is helping develop a research project on Chagas disease, a tropical parasitic infection prevalent in Latin America that can cause congestive heart failure and gastrointestinal complications if left untreated. The project will bring together clinicians practicing at health centers in New York, Florida, Texas, and California and basic scientists from multiple institutions to help the communities that are most impacted.

“The SNFiRU international advisory board convenes globally recognized leaders with distinguished biomedical expertise, unrivalled experience in pandemic preparedness and response, and a shared commitment to translating scientific advancements into equitably distributed benefits in real-world settings,” says SNF Co-President Andreas Dracopoulos. “The advisory board will advance the institute’s indispensable mission, which SNF is proud to support as a key part of our Global Health Initiative, and we look forward to seeing breakthroughs in the lab drive better outcomes in lives around the globe.”

The new advisory board will hold its first meeting on April 11th, 2024, following the second annual SNF Institute for Global Infectious Disease Research Symposium at Rockefeller.

Its members are: Rafi Ahmed of Emory University School of Medicine, Cori Bargmann of The Rockefeller University, Yasmin Belkaid of the Pasteur Institute, Anthony S. Fauci, the former director of the National Institute of Allergy and Infectious Diseases, Peter Hotez of Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development, Esper Kallas of of the Butantan Institute, Sharon Lewin of the University of Melbourne Doherty Institue, Carl Nathan of Weill Cornell Medicine, Rino Rappuoli of Fondazione Biotecnopolo di Siena and University of Siena, and Herbert “Skip” Virgin of Washington University School of Medicine and UT Southwestern Medical Center.


Read More

Continue Reading

Trending